CAPTRUST Financial Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-180
| Closed | -$9K | – | 2283 |
|
|
2022
Q2 | $9K | Hold |
180
| – | – | ﹤0.01% | 3789 |
|
|
2022
Q1 | $11K | Hold |
180
| – | – | ﹤0.01% | 3733 |
|
|
2021
Q4 | $15K | Hold |
180
| – | – | ﹤0.01% | 3468 |
|
|
2021
Q3 | $17K | Hold |
180
| – | – | ﹤0.01% | 3264 |
|
|
2021
Q2 | $18K | Hold |
180
| – | – | ﹤0.01% | 3164 |
|
|
2021
Q1 | $15K | Hold |
180
| – | – | ﹤0.01% | 3181 |
|
|
2020
Q4 | $16K | Hold |
180
| – | – | ﹤0.01% | 2346 |
|
|
2020
Q3 | $13K | Hold |
180
| – | – | ﹤0.01% | 2170 |
|
|
2020
Q2 | $13K | Buy |
+180
| New | +$13K | ﹤0.01% | 2089 |
|
|
2019
Q4 | – | Sell |
-180
| Closed | -$8K | – | 1088 |
|
|
2019
Q3 | $8K | Hold |
180
| – | – | ﹤0.01% | 1556 |
|
|
2019
Q2 | $9K | Hold |
180
| – | – | ﹤0.01% | 1520 |
|
|
2019
Q1 | $10K | Hold |
180
| – | – | ﹤0.01% | 1378 |
|
|
2018
Q4 | $8K | Hold |
180
| – | – | ﹤0.01% | 1255 |
|
|
2018
Q3 | $13K | Hold |
180
| – | – | ﹤0.01% | 1148 |
|
|
2018
Q2 | $10K | Hold |
180
| – | – | ﹤0.01% | 1163 |
|
|
2018
Q1 | $9K | Hold |
180
| – | – | ﹤0.01% | 1045 |
|
|
2017
Q4 | $10K | Hold |
180
| – | – | ﹤0.01% | 977 |
|
|
2017
Q3 | $10K | Buy |
180
+80
| +80% | +$4.44K | ﹤0.01% | 433 |
|
|
2017
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 240 |
|